217 related articles for article (PubMed ID: 15103681)
21. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry.
Merchant M; Weinberger SR
Electrophoresis; 2000 Apr; 21(6):1164-77. PubMed ID: 10786889
[TBL] [Abstract][Full Text] [Related]
22. The value of surface enhanced laser desorption/ionization-time of flight mass spectrometry at the diagnosis of non-small cell lung cancer: a systematic review.
Jiang F; Zhou XY; Huang J
Technol Cancer Res Treat; 2014 Apr; 13(2):109-17. PubMed ID: 23862745
[TBL] [Abstract][Full Text] [Related]
23. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
[TBL] [Abstract][Full Text] [Related]
24. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
25. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
[TBL] [Abstract][Full Text] [Related]
26. The application of SELDI-TOF-MS in clinical diagnosis of cancers.
Liu C
J Biomed Biotechnol; 2011; 2011():245821. PubMed ID: 21687541
[TBL] [Abstract][Full Text] [Related]
27. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
28. Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
Fowler LJ; Lovell MO; Izbicka E
Mod Pathol; 2004 Aug; 17(8):1012-20. PubMed ID: 15195106
[TBL] [Abstract][Full Text] [Related]
29. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.
Issaq HJ; Veenstra TD; Conrads TP; Felschow D
Biochem Biophys Res Commun; 2002 Apr; 292(3):587-92. PubMed ID: 11922607
[TBL] [Abstract][Full Text] [Related]
30. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
31. Screening of serum protein biomarkers in hemorrhagic cerebral infarction by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology.
Han Z; Wen L; Feng L
Ann Transl Med; 2020 Sep; 8(18):1186. PubMed ID: 33241035
[TBL] [Abstract][Full Text] [Related]
32. Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.
Cairns DA; Perkins DN; Stanley AJ; Thompson D; Barrett JH; Selby PJ; Banks RE
BMC Bioinformatics; 2008 Dec; 9():519. PubMed ID: 19055809
[TBL] [Abstract][Full Text] [Related]
33. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
34. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye.
Grus FH; Podust VN; Bruns K; Lackner K; Fu S; Dalmasso EA; Wirthlin A; Pfeiffer N
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):863-76. PubMed ID: 15728542
[TBL] [Abstract][Full Text] [Related]
35. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
[TBL] [Abstract][Full Text] [Related]
37. Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.
Becker AM; Das S; Xia Z; Liu Z; Adam BL; Kountakis SE
Am J Rhinol; 2008; 22(2):139-43. PubMed ID: 18416969
[TBL] [Abstract][Full Text] [Related]
38. Surface-enhanced laser desorption ionization/time-of-flight (SELDI-TOF) mass spectrometry (MS) as a phenotypic method for rapid identification of antibiotic resistance.
Dubska L; Pilatova K; Dolejska M; Bortlicek Z; Frostova T; Literak I; Valik D
Anaerobe; 2011 Dec; 17(6):444-7. PubMed ID: 21624485
[TBL] [Abstract][Full Text] [Related]
39. [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers].
Tian WD; Zeng ZY; Yu WB; Li XP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1282-7. PubMed ID: 20584658
[TBL] [Abstract][Full Text] [Related]
40. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.
Seibert V; Wiesner A; Buschmann T; Meuer J
Pathol Res Pract; 2004; 200(2):83-94. PubMed ID: 15237917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]